Second quarter 2014 sales increased 7% to $235 million year-over-year; Adjusted EBITDA increased 9% to $35 million
Full year 2014 guidance raised
Share repurchase program authorized by Board of Directors
PORTLAND, Ore., Aug.
Sign-up for Former Louisiana Attorney General and KSF Announce Appointment as Lead Counsel in CytRx Securities Fraud Lawsuit: Secondary Offering Shareholders (January 31, 2014) Should Inquire for More Information -- CYTR investment picks
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.